Our Leadership
Sujay Jadhav, MBA
CHIEF EXECUTIVE OFFICER
Ashish Gupta
CHIEF FINANCIAL OFFICER
Elliot Zimmerman
CHIEF COMMERCIAL OFFICER
Sujay Jadhav, MBA
CHIEF EXECUTIVE OFFICER
Sujay Jadhav is the Chief Executive Officer at Verana Health where he is helping to accelerate the company’s growth and sustainability by advancing clinical trial capabilities, data-as-a-service offerings, medical society partnerships, and data enrichment.
Sujay joins Verana Health with more than 20 years of experience as a seasoned executive, entrepreneur, and global business leader. Most recently, Sujay was the Global Vice President, Health Sciences Business Unit at Oracle, where he ran the organization’s entire product and engineering teams. Before Oracle, Sujay was the CEO of cloud-based clinical research platform goBalto, where he oversaw the acquisition of the company by Oracle. Sujay is also a former executive for the life sciences technology company Model N, where he helped to oversee its transition to a public company.
Sujay holds an MBA from Harvard University and a bachelor’s degree in electronic engineering from the University of South Australia.
Why Verana?
“We are at an inflection point in digital health. We now have the opportunity to transform patient care and cure by extracting quality insights from unfiltered, real-world healthcare data. Verana Health is poised to affect real change by defining and delivering the highest standards of data integrity to power healthcare."
Ashish Gupta
CHIEF FINANCIAL OFFICER
Ashish is the Chief Financial Officer (CFO) at Verana Health, leading the finance and legal functions. He has extensive experience scaling companies and developing growth initiatives. Ashish also possesses margin efficiencies and cash management expertise. He specializes in advancing companies to the next level and has worked across multiple verticals (edtech, martech, restaurant-tech) with startups that range in stage and size. He has also built and supported Sales Operations, Human Resources, Legal, Supply Chain, and Inventory Management teams. Ashish's most recent CFO role was at Presto, where he managed several fundraises through COVID-19 and helped lead the organization from Series B to a public company on Nasdaq in a very challenging market.
Why Verana?
“I am excited about Verana Health's potential to leverage real-world data and analytics in the health tech vertical with the support of a seasoned investor base."
Elliot Zimmerman
CHIEF COMMERCIAL OFFICER
Elliot Zimmerman is the Chief Commercial Officer at Verana Health where he oversees Business Development and Sales, Customer Management, Delivery and Customer Support.
Elliot brings 25+ years of leadership experience in enterprise software and services, overseeing sales, account management, delivery, support, compliance, and data security teams. Before joining Verana Health, he was CEO of Real Life Sciences for five years, where he led the business to a 15× increase in ARR and achieved positive EBITDA, leading to its acquisition by MediSpend, Inc. in January 2025. Previously, Elliot served as COO of goBalto until its acquisition by Oracle in 2018, and held leadership roles at Model N and Manugistics.
Elliot holds a Bachelor of Science degree in Business Logistics from the University of Maryland.
Why Verana?
“I joined Verana Health because I believe in the power of data to improve lives. Verana’s ability to transform complex, real-world clinical information into trusted insights has a direct and meaningful impact on patient care. I was drawn to the mission, the caliber of the team, and the opportunity to help scale solutions that not only advance life sciences research but also make a tangible difference for patients and providers."
Andrea Sim
CHIEF PRODUCT OFFICER
C.K. Wang
General Manager of Oncology & Chief Medical Officer
Aracelis Torres, PhD, MPH
CHIEF DATA & SCIENCE OFFICER
Andrea Sim
CHIEF PRODUCT OFFICER
Andrea Sim is the Chief Product Officer at Verana Health where she oversees product management, program management, clinical informatics, and data normalization.
Andrea has more than two decades of product management and healthcare technology experience. Prior to joining Verana Health, Andrea was the Vice President of Product for the Health Sciences Business Unit at Oracle. Andrea came to Oracle through the acquisition of goBalto, Inc., where she also was the Vice President of Product. Before that, Andrea was with RelayHealth for nearly a decade, where she most recently served as Vice President of Product Management. She was part of the product management team for more than six years, holding responsibility for product strategy, research, and strategic initiatives for Health Information Exchange (HIE) and clinical integration. Before that, Andrea served in various product management and consulting roles for Oracle, WebMD, and First Consulting Group.
Andrea holds a Bachelor of Arts degree in Molecular Cell Biology from University of California Berkeley.
Why Verana?
“Getting to use my experience in healthcare technology product management to make an impact on the quality of patient care is rewarding. What Verana Health is doing is important, difficult, and exciting. Each day is a challenge that’s full of opportunities to grow and innovate."
C.K. Wang
General Manager of Oncology & Chief Medical Officer
C.K. Wang is the General Manager of Oncology and Chief Medical Officer at Verana Health where he oversees the oncology division and serves as the clinical lead for the company.
C.K. joined Verana Health through a merger with COTA where he served as the Chief Medical Officer for six years and, under his tenure as Chief Executive Officer, finalized COTA's merger with Verana Health. During his time at COTA, C.K. launched the company's research services and helped establish COTA as the premier hematologic oncology real-world solutions provider. Prior to COTA, C.K. served in numerous leadership roles within IBM Watson Health's Oncology and Genomics division supporting clients and partners on a global basis. Previous to IBM Watson Health, C.K. spent 12+ years in clinical practice where he focused on establishing oncology practices and cancer programs.
C.K. holds a B.A. in Biology from Washington University in St. Louis and received his medical degree from the University of Texas Medical School in San Antonio. He completed his internal medicine residency at the University Hospitals of Cleveland/ Case Western Reserve University and his hematology and oncology fellowship at the University of Texas Southwestern Medical Center. He is board certified in medical oncology.
Why Verana?
"I came to Verana Health due to our shared belief in the ability of RWD/RWE to accelerate therapeutic discovery and improve patient lives. Having been in the real-world data space for 7+ years prior to joining Verana Health, I developed an appreciation for the complexities in developing high-quality real-world data assets and have always had the utmost respect for Verana and its offerings. I firmly believe that Verana Health is uniquely positioned to transform the landscape of real-world data and evidence."
Aracelis Torres, PhD, MPH
SENIOR VICE PRESIDENT, DATA & SCIENCE
Aracelis Torres, PhD, MPH, is Senior Vice President of Data & Science, where she oversees the Quantitative Sciences team working on rigorous methodology to generate sound scientific evidence from real-world data, as well as the commercial services and operations team that manage client deliverables. Dr. Torres is an epidemiologist with over ten years of academic and industry experience. Prior to joining Verana Health, she was a Director of Quantitative Sciences at Flatiron Health, where her work focused on translation of real-world oncology data to generate evidence. While at Flatiron Health, she led efforts related to the development of real-world endpoints, novel study designs, and prospective evidence generation while also serving as the Quantitative Sciences lead for the organization’s broader research collaboration with the FDA. She is also currently an Adjunct Professor at Columbia University Graduate School of Arts and Sciences, where she teaches a course on large-scale data processing and analysis.
Dr. Torres received a PhD in Cancer Epidemiology from Johns Hopkins Bloomberg School of Public Health, an MPH in Chronic Disease Epidemiology from Yale University’s School of Public Health, and a BS in Molecular, Cellular, and Developmental Biology from Yale University.
Why Verana?
“Verana’s mission to rigorously generate insights from real-world data is both inspiring and exciting. It provides a unique opportunity to tackle some of the toughest challenges in clinical research while keeping patients at the forefront of our work."
Ravi Rangaswamy
SENIOR VICE PRESIDENT OF ENGINEERING
Monica Matta
Chief Operating Officer of Oncology
Derek Sidebottom
CHIEF PEOPLE OFFICER
Ravi Rangaswamy
SENIOR VICE PRESIDENT OF ENGINEERING
Ravi Rangaswamy is Senior Vice President of Engineering, where he is responsible for the data engineering, applications, QA, and devops teams at Verana Health. Ravi has 25 years of experience in developing products across different domains and technology. Prior to joining Verana Health, Ravi was Vice President of Product Development at Oracle, leading the development Study Startup suite of products in the Oracle Health Sciences Business Unit. Ravi came into Oracle through the acquisition of goBalto, where he was Vice President of Engineering. Before that Ravi was at Oracle working on integration and business process management software.
Ravi holds Master of Science degrees in Computer Science and Industrial and Manufacturing Systems Engineering from Iowa State University and a bachelor's degree in Mechanical Engineering from University of Madras.
Why Verana?
“I joined Verana Health because of the opportunity to make an impact in improving patient outcomes and, enhancing clinical research. Being able to work alongside others in solving challenging technical problems to help achieve Verana Health's mission is exciting and a great opportunity."
Monica Matta
Chief Operating Officer of Oncology
Monica Matta is the Chief Operating Officer of Oncology at Verana Health, where she oversees operations, product execution, and cross-functional strategy in support of delivering high-quality oncology real-world data.
Monica brings over 15 years of experience in healthcare operations, data-driven product development, and technology-enabled business transformation. Prior to joining Verana, Monica served in the dual role of COO and CTO at COTA, where she led COTA's provider business, product, technology, client delivery, clinical data, and service line operations. She additionally led business and strategy efforts across COTA's network of healthcare providers, expanding portfolio assets by 10x and supporting company revenue increase by 4x during her tenure. Previously, Monica worked in management consulting in roles focused on building and scaling data-driven healthcare organizations, serving healthcare providers in the U.S. and abroad.
Monica holds a Bachelor's Degree in Public Health from the University of North Carolina at Chapel Hill.
Why Verana?
"I joined Verana Health for the opportunity to work with exceptional people who are building something that really matters. Verana is unique in its commitment, vision and ability to use data to create real impact in healthcare. I am excited to be part of a company where smart teams, strong values, and meaningful work come together to drive lasting change."
Derek Sidebottom
CHIEF PEOPLE OFFICER
Derek Sidebottom is an executive Human Resources leader and strategic advisor who oversees people strategy, organizational design, and global talent operations. With 25 years of experience across Private Equity, Venture Capital, and public markets, Derek partners with founders and boards to architect high-performing organizations and drive challenging business outcomes.
Derek brings over two decades of experience leading the HR function through monumental periods of change in the FinTech, SaaS, AI, and Interactive Entertainment sectors. Prior to his current advisory roles, Derek served as an HR executive at several high-growth organizations where he led people transformations through two IPOs and managed five successful M&A integrations. His operational track record includes driving 10x hypergrowth scale-ups while expanding global distributed operations across North America, EMEA, and APAC.
Derek holds an MBA from Athabasca University, a Bachelor of Arts in Psychology from L’Université d’Ottawa, and a Graduate Diploma in Human Resources Management from Humber College.
Why Verana?
“My ‘why’ is simple: Verana offers the unique challenge of building a world-class culture at the intersection of data and healthcare. By supporting the people who accelerate medical innovation, we aren’t just building a company—we’re helping save lives through organizational excellence.”
Our Medical Advisors
Urology
Ophthalmology
Ophthalmology
Neurology, Ophthalmology
Our Medical Advisors
Neurology, Ophthalmology
Our Advisors
Co-Founder,
Verana Health and Lagunita Biosciences
Strategic Advisor
Ahmanson Professor in Ophthalmology,
Stein Eye Institute, UCLA
Our Advisors
Ahmanson Professor in Ophthalmology,
Stein Eye Institute, UCLA
Our Board
Founding Partner,
Kleiner, Perkins, Caufield & Byers
Physician in Chief at Hackensack Meridian Health Oncology Transformation Service,
Chairman & Chief Physician Officer at John Theurer Cancer Center
Director of Strategy & Corporate Development,
Varian
Sujay Jadhav, MBA
CEO,
Verana Health
Partner,
Novo Holdings
David W. Parke II, MD
Former Chief Executive Officer,
American Academy of Ophthalmology
Chief Executive Officer,
American Urological Association
Co-Founder and Managing Director,
Biomatics Capital Partners
VP of Venture Investments, Johnson & Johnson Innovation - JJDC, Inc.
Managing Partner, GV
Principal,
Deerfield Management
Chief Investment Officer and Founder,
Casdin Capital
Principal,
Merck
Chief Executive Officer and Chairman,
Outcomes Matter Innovations
David W. Parke II, MD (Executive Chairman)
FORMER CHIEF EXECUTIVE OFFICER
Dr. Parke served from 2009 to 2022 as the Chief Executive Officer of the American Academy of Ophthalmology. He is now Executive Chairman of Verana Health, Inc. and remains CEO Advisor at the Academy.
After undergraduate education at Stanford University and medical school of Baylor College of Medicine, Dr. Parke completed residency training and chief residency at Baylor’s Cullen Eye Institute followed by fellowships in diseases and surgery of the retina and vitreous. He served for 17 years as president and chief executive officer of the Dean McGee Eye Institute and Professor and Chair of the Department of Ophthalmology at the University of Oklahoma. After serving as president of the American Academy of Ophthalmology in 2008, Dr. Parke was chosen to become its full-time CEO. He has served on the boards of companies in the insurance and digital health space. He is Past-President of the Council of Medical Specialty Societies.
Dr. Parke has been president of the Association of University Professors of Ophthalmology and director of the American Board of Ophthalmology. In 2009 he was elected to Academia Ophthalmologica Internationalis. His most recent professional and scholarly activities have centered on health policy and economics, on biomedical organizational leadership and development, and on big data analytics.
Our Investors
Verana Health is backed by leading institutional investors and industry veterans:
Brook Byers, founding member and senior partner of Kleiner, Perkins, Caufield, and Byers.